By Matt Jones

NEW YORK (GenomeWeb News) – Since premarket studies are not likely to fully answer questions about the safety and effectiveness of genetic tests, those that are sold directly to consumers should be regulated through a system that incorporates risk-stratification and post-market surveillance, according to a new policy opinion proposal published today in Science.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.